Abstract. Tumor necrosis factor-α (TNFα) is a multifunctional cytokine that was first described as a tumoricidal factor produced by activated macrophages. Extensive research over the last two decades has suggested that TNFα has physiologically diverse actions in ovarian function in a variety of species. TNFα and its specific receptors are present in the ovaries of many species. Furthermore, TNFα plays multiple and probably important roles in corpus luteum (CL) function as well as ovarian cell function throughout the estrous cycle. This review focuses on recent studies documenting TNFα in ovarian follicles and CL in several mammals. In addition, possible roles of TNF α in ovarian function throughout the estrous cycle and in the gestation period are discussed.
Disulfide bonds between "cysteine-rich domains" are the hallmark of the TNFα receptor superfamily. Two immunologically distinct TNFα receptors of approximately 55 kDa (Type I; TNF-RI) and 75 kDa (Type II; TNF-RII) have now been identified [4] . TNF-RI and TNF-RII have different intracellular signaling pathways [5] . TNF-RI contains an intracellular death domain, which is required for signaling pathways associated with apoptosis. In contrast, TNF-RII can induce gene transcription fo r cell surviva l, growth, a nd differentiation.
The expression of TNFα and TNFα receptors in the ovaries, and the methods used for detecting TNFα and TNFα receptors are shown in Tables 1  and 2 . TNFα and its receptors are present in the ovarian follicles or the corpus luteum (CL) of many species. There is increasing evidence that TNFα produced locally in the ovary modulates ovarian and CL function. This review focuses on studies documenting the roles of TNFα in the ovary, with emphasis on TNFα and its receptors in the CL. Furthermore, possible actions of TNFα in ovarian function throughout the estrous cycle and in the gestation period are discussed.
TNFα in Follicular Development and Luteal Formation
Immunoreactive or bioactive TNFα is present in follicles during follicular development in a variety of animals [6, 7, [14] [15] [16] 20] . Likewise, TNFα receptors are present on granulosa and theca cells [21, 24, 27] . From a functional standpoint, TNFα has been shown to inhibit follicle stimulating hormone (FSH)-, insulin-or insulin-like growth factor-I (IGF)-induced estradiol-17β (E2) production in granulosa cells [21, 28] and luteinizing hormone (LH)-stimulated androstenedione production in theca cells [28] . These observations have led to the idea that TNFα plays one or more physiological roles in regulating follicular cell function. One possible role of TNFα in the follicles is to mediate th e mec hanis m o f ov ulat io n. In co w s, th e maximum levels of bioactive TNFα are observed in t h e d o m i n a n t f o l l i c l e s [ 6 ] . I n a d d i t i o n , intrafollicular injection of TNFα antibodies after administration of GnRH blocked ovulation in sheep [18] . Other studies focusing on the role of TNFα in ovulation have been conducted in rats [29] [31, 32] . Since TNFα and its receptors are present in atretic follicles [7, 21] , TNFα may be one of the local regulators that induce apoptosis at the t im e o f fo ll ic le at r es ia t h ro u gh it s plas m a membrane receptors. TNFα and TNFα receptors are evident in the early stage CL in cows [9] , pigs [11, 26] , and humans [17] . TNFα is a potent stimulator of luteal prostaglandins (PGs) including PGF2α, PGE2, and PGI2 [9, 33, 34] . Luteal PGs are known to stimulate progesterone (P4) production from bovine CL in vitro, suggesting that they are luteotropic agents [35, 36] . Macrophages [1, 12] and endothelial cells [13] are sources of TNFα, and these cells infiltrate into the newly formed CL concomitant with vascular angiogenesis [37] . Thus, it could be assumed that TNFα contributes to the production of PGs by the early CL, and may partly promote the formation of the CL. Additional studies on human luteinized granulosa cells support a luteotropic role fo r TNFα [38 ] . This effect is not limited to steroidogenic cells since TNFα is capable of stimulating PGE2 secretion by bovine luteal endothelial cells [22] . Since both TNFα [39] and PGE2 [40] are known to affect the proliferation of endothelial cells derived from other tissues, TNFα and TNFα-induced PGE2 may be autocrine and/or paracrine regulators of vascular angiogenesis. Taken together, these findings suggest that TNFα has a role in stimulating the early phase of luteal development.
TNFα in Luteolysis
W he n an i m al s d o n ot b ec om e pr eg n an t , regression of the CL is essential for normal cyclicity since it allows the development of a new ovulatory f o l l ic l e . F u n c t i on a l r e g r e s si o n of th e C L , characterized by inhibition of P4 production, is fo l lo w ed by s t ru ct u ra l r egr es s io n . Dur i ng luteolysis, cells of the CL undergo apoptosis, a p r o c e s s t h a t h a s b e e n d e s c r i b e d u s i n g morphological and biochemical parameters in many domestic species including cows [41] , pigs [42] , and sheep [43] .
TNFα has an inhibitory effect on gonadotropinstimulated steroid production in steroidogenic luteal cells in rats [44] , pigs [45] , and cows [33] . Furthermore, LH receptor and steroidogenic acute regulatory protein mRNA are reduced by TNFα in rat CL [46] . Secretion of TNFα in bovine CL is higher in the late stage CL than in the mid-luteal phase CL [8, 9] . In addition, specific binding sites for TNFα are present in bovine CL throughout the luteal phase of the estrous cycle [9] . These studies suggest that TNFα affects CL funct io n as a luteolytic agent. However, how TNFα switches from a luteotropic agent to a luteolytic agent in the estrous cycle is unknown. Current investigations into synergistic or co-operative actions between TNFα and other substances may clarify these points.
It is well recognized that uterine-derived PGF2α is the primary initiator of luteolysis in many species, especially in ruminants. PGF2α decreases P 4 production of cultured luteal cells stimulated by gonadotropins in pigs [47] and cows [45] . PGF2α also increases endothelin-1 (ET-1) production from endothelial cells in the CL, and it is presumed that the elevated ET-1 augments PGF2α-induced inhibition of P4 synthesis [23] . Specific binding sites for TNFα are present in endothelial cells derived from bovine CL [22, 23] and ET-1 secretion by these cells is significantly stimulated by treatment with TNFα [22] . Since it has been shown that high concentrations of ET-1 decrease P 4 production of bovine luteal cells [48] , TNFα-induced ET-1 secretion from the endothelial cells may act on luteal cells as an anti-steroidogenic agent in the CL concomitant with endometrial PGF2α in cattle. Moreover, PGF2α-induced steroid reduction results in the activation of inflammatory cells followed by TNFα and interferon-γ (IFNγ) secretion in the CL of cows [49] , pigs [50] , and rabbits [51] . TNFα in combination w ith IFNγ reduces P4 production and the num ber of via ble cells , although TNFα alone shows little, if any, effect [33, 52] . Although, to date, there are no known studies demonstrating that IFNγ is present in the CL at the protein level, IFNγ mRNA has been detected in bovine luteal tissue collected at the end of the luteal phase of a naturally regressing CL and after induced luteolysis [49] . Treatment with IFNγ alone can decrease the P4 level and induce apoptosis [52] . Realistically, however, it is likely that TNFα works only in conjunction with IFNγ or other substances (e.g., ET-1 etc.) to inhibit P4 synthesis (i.e., functional regression).
In contrast to ruminants, the CL of pigs, rodents, and primates are known to secrete E2 as well as P4. Intraluteal E2 is a potent luteotropic factor, namely it stimulates P4 secretion in the CL of pigs [53] . It has been demonstrated that PGF2α inhibits P4 secretion by porcine luteal cells in vitro, whereas it stimulated E 2 production [45] . Moreover, when the CL is pretreated with TNFα, PGF2α reduces P4 production more markedly than treatment with PG F2α alone [53] . Sin ce TN F α i nhi bit s E2 production of cultured luteal cells [11] , TNFα may reduce the P4 level not only by direct inhibition of P4 secretion but also by inhibiting luteotropic E2 production in the CL of pigs. However, in humans, it has been shown that E2 is not a luteotropic agent [54] . Thus, the mechanisms of TNFα-mediated inhibition of P4 secretion seem to differ among species.
T h e im p o r t an c e o f i n t er ac t i o ns be t w ee n cytokines (i.e., TNFα, IFNγ) and the Fas/Fas ligand (Fas L) system in structural luteolysis has been demonstrated. The engagement of Fas with Fas L is primarily known for its role in apoptosis in various cell types [55] . Bovine luteal cells become sensitive to Fas L-induced cell death in the presence of IFNγ and IFNγ in combination with TNFα [56] . IFNγ and TNFα have been shown to stimulate Fas mRNA expression in a variety of ovarian cell types [56, 57] . Moreover, the increased sensitivity of bovine luteal cells to Fas L is correlated with an increase in Fas m R N A e x p r e s si o n i n d u c e d b y c y to k i n e s, suggesting that Fas L induces cell death of bovine luteal cells mediated via the Fas/Fas L system [56] .
The number of leukocytes increases at the time of luteolysis in the CL [49] [50] [51] . Interactions between TNFα and IFNγ are also considered to be important in the structural regression of the CL. A decrease in the P4 level and interruption of growth factor signaling in the CL may promote activation of inflammatory cells resulting in increased TNFα and IF Nγ p r odu c ti on [50, 51 ] . T N Fα in du c es a significant increase in the expression of major histocompatibility (MHC) class I glycoproteins in cultured bovine luteal cells [33] . It is hypothesized tha t these glycopro teins a re reco gnized by cyto tox ic T lymphoc yt es in ord er for the T lymphocytes to phagocytize the luteal cells [33] . IFNγ also increases the expression of class II MHC [58] . In addition, IFNγ alone reduces the viability of bov in e and m ur in e lu teal c ells , and T N Fα augments this effect [33, 53, 56] . Since IFNγ upregulates TNFα receptors in a variety of cell types [59] , the luteal cells might become more sensitive to the action of TNFα in the presence of IFNγ. These findings support the idea that TNFα and IFNγ also play important roles in luteolysis, especially at the time of structural regression.
Intracellular Signaling of TNFα in Luteal Cells
Our previous research demonstrated that TNF-RI mRNA and specific binding sites for TNFα are present in bovine CL throughout the estrous cycle, and suggested that at least one of the receptors for TNFα in bovine CL is TNF-RI [9] . The TNFα/TNF-RI complex activates phospholipase (PL)-A2 to produce PGF2α in bovine steroidogenic luteal cells [60, 61] . In addition, TNFα activates the mitogenactivated protein kinase (MAPK) kinase/MAPK signaling cascade which subsequently activates the PL-A2 pathway in bovine luteal cells to produce arachidonic acid and PGs [60] . Also, TNFα is known to activate cell survival pathways, involving activation of nuclear factor-κB (NFκB) [62] . NFκB has been shown to control the transcription of the cyclooxygenase (COX)-2 gene [63] . COX-2 is an inducible key rate-limiting enzyme for converting arachidonic acid to the PG family [64] . Therefore, TN F α-indu ced PG pr od uction m ay also be regulated by activation of NFκB and subsequent promotion of COX-2 expression.
More recently, it has been shown that TNFα-induced signaling in steroidogenic luteal cells results in an increase in phosphorylated p38 MAPK and jun-N-terminal kinase (JNK) [65] . Elevations in J N K a c ti v i t y h a v e b e e n sh o w n t o i n d u c e phosphorylation and inactivation of the Bcl-2 protein in KYM-1 cell lines [66] . Generally, one of the known effects of Bcl-2 is to suppress apoptotic cell death, and the intracellular level of Bcl-2 in human granulosa cells is reduced after stimulation with TNFα [67] . These observations suggest that T N F α m a y i n d u c e ap o p t o si s t h r o u g h th e inactivation of Bcl-2 protein following activation of JNK in the luteal cells. In addition, the engagement of TNFα with TNF-RI has been demonstrated to activate sphingomyelin-ceramide pathways, which result in apoptosis in some cell types [68] . The multiple actions of TNFα are due to the activation of complex intracellular signaling pathways [69] .
In contrast to TNF-RI, information on TNF-RII in the ovary is limited [70] . Recently, TNF-RII was demonstrated in the granulosa cells of porcine ovaries, and suggested to have a role in follicle atresia [70] . The physiological importance of TNF-RII in the CL is not completely understood.
Whether TNF-RII has any significance in the CL remains to be proven.
TNFα in the Gestation Period
When pregnancy is established, the CL is s us tained a nd co ntinuo us ly produces P4 to maintain the pregnancy. TNFα and its receptors have been shown to be present in the gravid uterus, placenta, oviducts, and embryo [71] . In the CL, it has been also demonstrated that high-affinity binding sites for TNFα are present throughout the gestation period, and that the concentration of TNFα receptors changes during the gestational stages [10] . Furthermore, TNFα mRNA has been detected in bovine [10] and porcine [11] CL during the gestation period. These findings suggest that locally produced TNFα plays one or more roles in the pregnant CL as an autocrine and/or paracrine mediator. Since the concentrations of TNFα receptors as well as the abundance of TNFα mRNA are high in the CL of the late gestation period [10] , it is possible that TNFα produced locally in the CL contributes to luteal resorption during or following parturition.
Specific binding sites for TNFα have also been fo u nd i n bo v in e C L o f t h e e arl y a nd m i dgestational stages [10] . Furthermore, the affinity and concentration of the receptors in CL of pregnancy are comparable to those in CL of the regressed stage [9] . Thus, TNFα may also act on CL function in the early and mid-gestational stages. TNFα stimulates PGE2 as well as PGF2α secretion by cultured bovine luteal cells in a dose-dependent fashion [9] . Both luteal PGE2 and PGF2α in the CL are known to be luteotropic agents, e.g., they stimulate P4 production by bovine CL in vitro [35, 36] . Therefore, it could be assumed that the luteal TNFα contributes to maintaining the pregnancy by stimulating the production of PGF2α and PGE2 by the CL of pregnancy, indirectly resulting in an increase in P4 output from the CL of pregnancy. The bovine CL from day 200 of pregnancy secretes more PGE2 and PGF2α in vitro than the CL at day 14 of the estrous cycle [72] . Furthermore, P4 production in vitro by day 200 CL of pregnancy was increased by PGE2 but not by LH [73] . These findings may support the above supposition that TNFα indirectly contributes to P4 production by stimulating luteal PGE2 in bovine CL during the gestation period.
Conclusions
Our observations and those of others suggest that TNFα plays multiple and important roles in ovarian function via its specific receptors. The possible actions of TNFα in the ovary can be summarized as follows (Fig. 1). 1. TNFα affects early follicular growth, and plays one or more roles in establishing follicle atresia and ovulation.
2. TNFα has two distinct roles depending on the phase of luteal development. TNFα seems to play a luteotropic role through stimulation of luteal PGF2α and PGE2 secretion in the early luteal phase. On the other hand, luteolytic events, i.e., functional and structural luteolysis, are induced by this cytokine in combination with other factors (Fas L, PGF2α, or IFNγ). IFNγ appears to be an important modulator of luteolysis, although the exact source and factors that contribute to IFNγ production in the CL are unknown.
3. Although the physiological significance of TNFα regulating CL function during gestation is still obscure, TNFα may play physiological roles in regulating CL function in the gestation period as well as in the estrous cycle. TNFα plays multiple roles in ovarian function depending on the phases of follicular and luteal development.
